Cargando…

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis

This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those with...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Shogo, Oe, Katsumasa, Kotani, Takuya, Okazaki, Ayana, Kiboshi, Takao, Suzuka, Takayasu, Wada, Yumiko, Shiba, Hideyuki, Hata, Kenichiro, Shoda, Takeshi, Takeuchi, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572948/
https://www.ncbi.nlm.nih.gov/pubmed/37833884
http://dx.doi.org/10.3390/ijms241914436
_version_ 1785120351804456960
author Matsuda, Shogo
Oe, Katsumasa
Kotani, Takuya
Okazaki, Ayana
Kiboshi, Takao
Suzuka, Takayasu
Wada, Yumiko
Shiba, Hideyuki
Hata, Kenichiro
Shoda, Takeshi
Takeuchi, Tohru
author_facet Matsuda, Shogo
Oe, Katsumasa
Kotani, Takuya
Okazaki, Ayana
Kiboshi, Takao
Suzuka, Takayasu
Wada, Yumiko
Shiba, Hideyuki
Hata, Kenichiro
Shoda, Takeshi
Takeuchi, Tohru
author_sort Matsuda, Shogo
collection PubMed
description This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25–15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03–1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA.
format Online
Article
Text
id pubmed-10572948
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105729482023-10-14 Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis Matsuda, Shogo Oe, Katsumasa Kotani, Takuya Okazaki, Ayana Kiboshi, Takao Suzuka, Takayasu Wada, Yumiko Shiba, Hideyuki Hata, Kenichiro Shoda, Takeshi Takeuchi, Tohru Int J Mol Sci Article This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25–15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03–1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA. MDPI 2023-09-22 /pmc/articles/PMC10572948/ /pubmed/37833884 http://dx.doi.org/10.3390/ijms241914436 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Matsuda, Shogo
Oe, Katsumasa
Kotani, Takuya
Okazaki, Ayana
Kiboshi, Takao
Suzuka, Takayasu
Wada, Yumiko
Shiba, Hideyuki
Hata, Kenichiro
Shoda, Takeshi
Takeuchi, Tohru
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title_full Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title_fullStr Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title_full_unstemmed Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title_short Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
title_sort serum complement c4 levels are a useful biomarker for predicting end-stage renal disease in microscopic polyangiitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572948/
https://www.ncbi.nlm.nih.gov/pubmed/37833884
http://dx.doi.org/10.3390/ijms241914436
work_keys_str_mv AT matsudashogo serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT oekatsumasa serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT kotanitakuya serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT okazakiayana serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT kiboshitakao serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT suzukatakayasu serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT wadayumiko serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT shibahideyuki serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT hatakenichiro serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT shodatakeshi serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis
AT takeuchitohru serumcomplementc4levelsareausefulbiomarkerforpredictingendstagerenaldiseaseinmicroscopicpolyangiitis